Physician profile
Jonathan D Thelen
NPI 1760614101
$1,794.78
in general payments reported to CMS, 2019-2025
12 companies · $514 in 2025
The $514 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $262 · 2022: $122 · 2023: $494 · 2024: $403 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,410.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,343.94 | 2021-2025 | |
| Nestle Healthcare Nutrition INC. | $86.72 | 2021-2022 | |
| Janssen Biotech, INC. | $66.91 | 2021-2025 | Simponi Aria, Stelara, Simponi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $66.10 | 2021-2023 | Xifaxan |
| Gilead Sciences, INC. | $55.77 | 2021-2023 | |
| Qol Medical, LLC | $48.68 | 2021-2023 | Sucraid |
| Celgene Corporation | $32.14 | 2023 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $26.57 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.35 | 2023 | Cyltezo |
| Intercept Pharmaceuticals, INC. | $17.07 | 2025 | |
| Braintree Laboratories, INC. | $14.10 | 2021 | |
| Boston Scientific Corporation | $13.43 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Thelen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.